The relationship between insulin-like growth factor I (IGF-I), a hormone which has potent metabolic effects and stimulates protein synthesis, and prolactin and oestradiol was examined to investigate a possible mechanism for the luteal cell hypertrophy that is responsible for the increase in size of the corpus luteum. A luteal cell line (GG-CL) derived from large luteal cells of the pregnant rat corpus luteum was used. IGF-I, 
Introduction
Many tropic hormones act on steroidogenic glands to increase not only steroidogenesis but also the size of their target tissues (Gibori, 1993; Juengel et ah, 1995 Juengel et ah, ,1997 . In rats, the corpus luteum more than doubles in size with the advance of pregnancy, mainly due to hypertrophy of the large luteal cells (McLean et ah, 1992) . It is well established that prolactin and luteal oestradiol act in concert to cause hypertrophy of the rat corpus luteum (Alloiteau, 1959) . However, the mechanism by which these tropic hormones affect corpus luteum hypertrophy is still unclear. The observation that only the large luteal cell responds to insulin¬ like growth factor I (IGF-I) stimulation and contains the bulk of the receptors for IGF-I (Parmer et ah, 1991) led to the proposal that this growth hormone may mediate, at least in part, prolactin and oestradiol action. IGF-I has potent metabolic effects and stimulates protein synthesis. Expression of IGF-I in the rat liver is stimulated by prolactin (Murphy et ah, 1988) and the expression of its receptor is upregulated by oestradiol in a variety of tissues (Murphy and Ghahary, 1990; Adesanya et ah, 1996; Clarke et ah, 1997) . These observations led to the hypothesis that prolactin stimulates IGF-I expression, whereas oestradiol upregulates expression of the IGF-I receptor. However, administration of oestradiol in vivo caused a marked decrease in IGF-I receptor expression in the corpus luteum of pregnant rats (Parmer et ah, 1991) . This oestradiol-induced downregulation may be due to progesterone, since oestradiol stimulates progesterone production by the rat corpus luteum and progesterone is known to inhibit expression of the IGF-I receptor and its ligand in several tissues (Papa et ah, 1991; Strowitzki et ah, 1996; Manikkam and Rajamahendran, 1997 and 5'-TGAGTCTTGGGCATGTCAGT-3'), IGF-I receptor (5'-TCCACCATAGACTGGTCTCT-3' and 5'-ACGAAGCC-ATCTGAGTCACT-3') and oestrogen receptor ß (5'-GCCAA-TCATGTGCACCAGTTCCTT-3' and 5'-AAAGCCAAGAG-AAACGGTGGGCAT-3') were designed on the basis of each cDNA sequence (Roberts et ah, 1987; Werner et ah, 1989;  Kuiper et ah, 1996) . Each reaction also included primers (5'-CTGAAGGTCAAAGGGAATGTG-3' and 5'-GGACAGAG-TCTTGATGATCTC-3') to amplify ribosomal protein LI 9 or primers (5'-CGTTCACCTTGATGAGCCCATT-3' and 5'-TCCAAGGGTCCGCTGCAGTC-3') to amplify ribosomal protein S16. Both L19 and S16 were used as internal controls (Chan et al, 1987; Barra et al, 1991 (Fig. 1) . In addition, progesterone treatment of GG-CL cells had no inhibitory effect on the expression of IGF-I and IGF-I receptor mRNA (Fig. 2) . (Fig. 4) . Urban et ah (1994) reported that IGF-I downregulates IGF-I receptor mRNA expression in pig granulosa cells.
Thus, the effect of IGF-I on IGF-I receptor mRNA expression was also examined. IGF-I had no effect on IGF-I receptor mRNA expression in GG-CL cells (data not shown).
Developmental changes in IGF-I and IGF-I receptor mRNA concentrations in the corpus luteum throughout pregnancy and after parturition Corpora lutea were isolated on different days of pregnancy, the day of parturition, or the day after parturition to investigate the developmental changes in IGF-I and IGF-I receptor mRNA. IGF-I mRNA is constitutively expressed in the corpus luteum throughout pregnancy, but increases significantly from day 20 (Fig. 5a ). In contrast, the concentration of IGF-I receptor mRNA reaches a peak at day 9, and gradually decreases thereafter (Fig. 5b) .
Discussion
In pregnant rats, two luteal cell populations, small and large luteal cells, form the corpus luteum (Gibori, 1993) . Although the origin of the two luteal cell populations is uncertain, it is hypothesized that luteal cell size does not depend on follicular origin, but rather on the responsiveness of individual luteal cells to growth signals (Gibori, 1993) . It has been reported that large luteal cells respond to IGF-I stimulation and contain the bulk of the IGF-I receptors (Parmer et ah, 1991) , and that it is this population that undergoes hypertrophy during the development of the corpus luteum (McLean et ah, 1992 Oestradiol upregulates mRNA expression for both IGF-I and IGF-I receptor in non-steroidogenic tissues (Murphy and Fig. 3 . Effect of prolactin on (a) insulin-like growth factor I (IGF-I) and (b) IGF-I receptor mRNA expression in a luteal cell line (GG-CL) derived from the large luteal cells of the pregnant rat corpus luteum. GG-CL cells stably transfected with the long form of the prolactin receptor were incubated with prolactin (0.01, 0.1 and l.Opgmh1) for 8 h at 39°C. Total RNA was isolated and subjected to RT-PCR. The quantification data are mean ± SEM of three different experiments, a, < 0.01 versus control. Fig. 4 . Effect of insulin-like growth factor I (IGF-I) on oestrogen receptor ß mRNA expression in a luteal cell line (GG-CL) derived from the large luteal cells of the pregnant rat corpus luteum. GG-CL cells were incubated with recombinant human IGF-I (5, 50 and 100 ng ml-1) for 8 h at 39°C. Total RNA was isolated and subjected to RT-PCR. The quantification data are mean ± SEM of three different experiments, b, < 0.05 versus control. Ghahary, 1990; Adesanya et ah, 1996; Clarke et ah, 1997) , but downregulates expression of both mRNAs in the rat corpus luteum (Parmer et ah, 1991) . A luteal cell line (GG-CL) derived from the large luteal cells of the pregnant rat corpus luteum (Sugino et ah, 1998) (Sugino et al, 1997 (Sugino et al, , 1998 and thus the possibility that oestradiol action is mediated by progesterone is eliminated. Another advantage of these cells is that they are responsive to progesterone (Sugino et ah, 1997 (1995) reported that expression of IGF-I mRNA is high at the end of pregnancy. In rats, prolactin and placental lactogens (rPL-I and -II) secreted by the placenta may be responsible for maintaining the concentration of IGF-I mRNA until day 20. However, these hormones are not responsible for the increase in IGF-I mRNA expression after day 20 since, at this stage, a decrease in prolactin receptor expression occurs in the corpus luteum, which becomes non-responsive to prolactin and placental lactogen stimulation (Telleria et ah, 1997) . The increase in IGF-I expression at the end of pregnancy and after parturition, at a time when the corpus luteum is undergoing both functional and structural luteolysis, is intriguing. However, the increase in IGF-I binding protein 3 in corpora lutea undergoing luteolysis (Erickson et ah, 1993) probably neutralizes the action of IGF-I. The expression of IGF-I receptor mRNA in the corpus luteum appears to be the opposite to that of IGF-I.
However, the decline in the number of receptors does not appear to be induced by IGF-I, since IGF-I had no effect on IGF-I receptor expression, and it may be due to oestradiol produced locally by the corpus luteum. Oestradiol concentrations in the corpus luteum increase in the second half of pregnancy (Taya and Greenwald, 1981) and oestradiol inhibits IGF-I receptor expression both in vivo (Parmer et ah, 1991) and in vitro, as observed in the present study.
In summary, the results of the present study indicate that prolactin stimulates the expression of IGF-I mRNA in luteal cells, which in turn upregulates the expression of oestradiol receptor ß. The results also indicate that there is a feedback mechanism between IGF-I and oestradiol action. Whereas IGF-I stimulates oestradiol receptor expression, oestradiol downregulates the concentration of the IGF-I receptor and its ligand.
